SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-06-12 00:18
Tx date 2026-06-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-13,258.95
-176,786 vol
$0.075 each 		2,847,939
Filed 2026-06-12 00:16
Tx date 2026-06-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+392,857 vol 		3,024,725
Filed 2026-06-12 00:14
Tx date 2026-06-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-392,857 vol 		0
Filed 2025-12-14 18:14
Tx date 2025-12-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
56 - Grant of rights
+392,857 vol 		392,857
Filed 2025-12-14 18:12
Tx date 2025-12-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+392,858 vol 		2,631,868
Filed 2025-12-14 18:10
Tx date 2025-12-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-392,858 vol 		0
Filed 2025-07-14 07:51
Tx date 2025-07-14 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-360,000
-300,000 vol
$1.20 each 		0
Filed 2025-06-25 12:48
Tx date 2025-06-23 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+196,428 vol 		2,239,010
Filed 2025-06-25 12:47
Tx date 2025-06-23 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+196,428 vol 		2,042,582
Filed 2025-06-25 12:46
Tx date 2025-06-23 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-196,428 vol 		392,858
Filed 2025-06-25 12:45
Tx date 2025-06-23 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-196,428 vol 		589,286
Filed 2025-06-25 12:31
Tx date 2025-06-20 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
56 - Grant of rights
+392,857 vol 		785,714
Filed 2024-12-24 16:36
Tx date 2024-12-20 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
56 - Grant of rights
+392,857 vol 		392,857
Filed 2024-12-11 18:34
Tx date 2024-12-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+423,077 vol 		1,846,154
Filed 2024-12-11 18:33
Tx date 2024-12-09 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-423,077 vol 		0
Filed 2024-06-28 01:22
Tx date 2024-06-24 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+423,077 vol 		1,423,077
Filed 2024-06-28 01:21
Tx date 2024-06-24 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights
-423,077 vol 		423,077
Filed 2023-12-28 17:20
Tx date 2023-12-22 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
46 - Compensation for services 		$55,000
+846,154 vol
$0.065 each 		846,154
Filed 2023-12-28 17:10
Tx date 2020-07-13 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-10 15:37
Tx date 2023-03-05 		$LABS
MediPharm Labs Corp. 		Taves, Christopher David
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$-490,000
-700,000 vol
$0.70 each 		0